Spiracheck

SpiraCheck is a medical technology and diagnostics business developing non-invasive breath testing for the early detection of cancer. Its work centres on analysing volatile organic compounds in breath to identify biomarkers associated with gastrointestinal and other cancers. The company’s services and technology are aimed at supporting clinicians with earlier, simpler and less invasive screening, potentially helping to prioritise patients for further investigation and reduce reliance on invasive diagnostic procedures. Operating in the health technology, oncology diagnostics and clinical research sectors, SpiraCheck combines biomarker science, patented methods and clinical validation to improve cancer detection and patient outcomes.